相关实验视频

Updated: Jan 17, 2026

Dynamic Clamp Methods to Investigate Impaired Neuronal Excitability Associated with Autism

Dynamic Clamp Methods to Investigate Impaired Neuronal Excitability Associated with Autism

Published on: October 17, 2025

在德拉维特综合征中通过缓慢的Na_V1.1无活化诱导去极化阻断

Louisiane Lemaire¹, Mathieu Desroches², Serafim Rodrigues^3,4

¹MathNeuro team, Inria Branch at the University of Montpellier, Montpellier, 34090, France. louisiane.lemaire@inria.fr.

Scientific reports

|September 24, 2025

概括

德拉维特综合征是一种严重的神经疾病,涉及NaV1.1通道的突变. 这些通道的缓慢失活会导致脱极化阻断,导致疾病病理.

科学领域:

神经科学是一个神经科学.
计算生物学计算生物学
分子生物学分子生物学

背景情况:

德拉维特综合征是一种严重的发育性和性脑病变.
对于抑制神经元功能至关重要的Na_V1.1通道的突变是大多数德拉维特综合征病例的基础.
之前的研究发现了由于突变导致的Na_V1.1通道失活的改变电压依赖性和动力学.

研究的目的:

在德拉维特综合征的背景下,研究Na_V1.1通道中改变缓慢无活化的特定作用.
探索这些突变造成的超出发射率降低的潜在发射赤字.

主要方法:

利用了快速激增的抑制神经元的计算模型.
采用了多次时间尺度分析,利用Na_V1.1通道失活的缓慢动力学.
模拟长时间刺激以观察持续活动下的通道行为.

主要成果:

计算机建模显示,改变Na_V1.1激活显著降低了射击速度.
在突变通道中较低电压的缓慢无活化开始在长时间刺激期间促进脱极化阻断.
突变通道中缓慢无活化的加速动力学加快了脱极化阻断的开始.

结论:

改变Na_V1.1通道的缓慢无活化代表了一些Dravet综合征变异的潜在致病机制.
由改变缓慢失活引起的脱极化阻断为德拉维特综合征中神经元功能障碍提供了另一种解释.
这项研究强调了Na_V1.1通道功能障碍对德拉维特综合征病理生理学的复杂贡献.

更多相关视频

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy

Published on: July 12, 2021

Patch Clamp Recordings on Intact Dorsal Root Ganglia from Adult Rats

Patch Clamp Recordings on Intact Dorsal Root Ganglia from Adult Rats

Published on: September 29, 2016

相关概念视频

Depolarizing Blockers: Mechanism of Action

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...

Depolarizing Blockers: Pharmocokinetics

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...